<< New doctors, teaching physicians disagree about essential medical procedures to learn | Hybrid metal and organic nanoparticles for targeting, imaging, and treating cancer >>
Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski

Nanosensor arrays ''sniff out" cancer

Published on April 27, 2009 at 4:36 PM · No Comments

In 2006 researchers established that dogs could detect cancer by sniffing the exhaled breath of cancer patients. Now, using nanoscale arrays of detectors, two groups of investigators have shown that a compact mechanical device also can sniff out lung cancer in humans.

Hossam Haick, Ph.D., and his colleagues at the Israel Institute of Technology in Haifa, used a network of 10 sets of chemically modified carbon nanotubes to create a multicomponent sensor capable of discriminating between a healthy breath and one characteristic of lung cancer patients. This work appears in the journal Nano News. Meanwhile, Silvano Dragonieri, M.D., University of Bari, Italy, and his colleagues used a commercial nanoarray-based electronic "nose" to discriminate between the breath of patients with non-small cell lung cancer  and chronic obstructive pulmonary disease (COPD). These results appear in the journal Lung Cancer.

The key development in Dr. Haick's team's work demonstrated that the electrical resistance of carbon nanotubes coated with nonpolymeric organic layers changes substantially when nonpolar organic molecules, such as those present in a breath, pass over the nanotubes. Uncoated nanotubes do not respond strongly to the type of nonpolar molecules found in the human breath.

Using 10 different organic coatings, the investigators created field-effect transistors comprising random networks of each of the different coated nanotubes, and the resulting array produces a characteristic change in electrical output when exposed to volatile nonpolar organic substances. A computational technique known as principal component analysis can decipher the complex signal change produced when mixtures of nonpolar organic molecules pass over the sensor network. When plotted in two dimensions, the data from a simulated set of "healthy" and "lung cancer" patients form two clear clusters that readily distinguish the two sets of patients. The investigators also showed that their device could identify healthy rats from those with chronic kidney failure.

Rather than designing their own device, Dr. Dragonieri's group used a Cyranose 320 built by Smiths Detection based in Pasadena, California. This hand-held electronic nose, which is used widely throughout the chemical and food processing industries, employs a nanocomposite sensor array to rapidly detect volatile organic compounds in the air.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading